Clinical Trials Logo

Clinical Trial Summary

The Vitamin D receptor gene (VDR) polymorphisms are the candidate genetic variants for susceptibility to autoimmune diseases. In the present study, the investigators aimed to assess the association between VDR polymorphisms and myasthenia gravis (MG) susceptibility and disease features in Chinese Han population.The patients with MG and healthy controls were genotyped for VDR rs1544410, rs2228570, rs731236, and rs7975232 polymorphisms using the improved multiple ligase detection reaction. Information on age at onset, acetylcholine receptor antibody (AChR-Ab) and muscle-specific kinase antibody (MuSK-Ab) status, thymus status, involved muscles at onset and Osserman type at the maximum worsening during 2 years follow-up were obtained and used as the grouping basis of sub-classifications. Intergroup comparisons of allele and genotype frequencies, haplotype distributions were performed between MG group and the control group, and between each pair of MG subgroups.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05380128
Study type Observational
Source Beijing Tongren Hospital
Contact
Status Completed
Phase
Start date June 1, 2017
Completion date May 9, 2022

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04735913 - Effects of Metabolic Enzymes and Transporter Gene Polymorphisms on the Pharmacokinetics and Metabolism of Oral Abiraterone Acetate in Healthy Chinese Adults Early Phase 1
Recruiting NCT06431789 - Prospective Observational Association Between SLCO1B1 Gene Polymorphism and the Anti-factor Xa Activity of Edoxaban in Patients With Moderate to Severe Renal Insufficiency
Recruiting NCT05503095 - PCSK9 Polymorphism and Risk of Cardiac Rupture
Recruiting NCT04960774 - Risk Factors for Severe Periodontitis in 30 to 40 Year Olds: a Retrospective Study